BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
- 7 October 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (40), 15517-15522
- https://doi.org/10.1073/pnas.0807841105
Abstract
We have used an inhibiting antibody to determine whether preimmune versus antigen-experienced B cells differ in their requisites for BLyS, a cytokine that controls differentiation and survival. Whereas in vivo BLyS inhibition profoundly reduced naïve B cell numbers and primary immune responses, it had a markedly smaller effect on memory B cells and long-lived plasma cells, as well as secondary immune responses. There was heterogeneity within the memory pools, because IgM-bearing memory cells were sensitive to BLyS depletion whereas IgG-bearing memory cells were not, although both were more resistant than naïve cells. There was also heterogeneity within B1 pools, as splenic but not peritoneal B1 cells were diminished by anti-BLyS treatment, yet the number of natural antibody-secreting cells remained constant. Together, these findings show that memory B cells and natural antibody-secreting cells are BLyS-independent and suggest that these pools can be separately manipulated.Keywords
This publication has 47 references indexed in Scilit:
- Phenotypic and functional heterogeneity of human memory B cellsSeminars in Immunology, 2008
- PD‐L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine bindingEuropean Journal of Immunology, 2007
- New markers for murine memory B cells that define mutated and unmutated subsetsThe Journal of Experimental Medicine, 2007
- Autoreactivity in Human IgG+ Memory B CellsImmunity, 2007
- Intrinsic properties of human and murine memory B cellsImmunological Reviews, 2006
- Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic EffectsToxicological Sciences, 2006
- Peritoneal and splenic B‐1 cells are separable by phenotypic, functional, and transcriptomic characteristicsEuropean Journal of Immunology, 2004
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999
- A rheumatoid factor transgenic mouse model of autoantibody regulationInternational Immunology, 1993
- Maintenance of B-cell memory by long-lived cells generated from proliferating precursorsNature, 1990